Metoclopramide vs Placebo for Prevention of Pneumonia in Acute Stroke

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 106 participants.

Also called NCT04873297

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 106 participants (enrolled count) (from the registry)
Sponsor
Shaheed Zulfiqar Ali Bhutto Medical University (from the registry)
Registry
  • NCT NCT04873297
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Pakistan (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04873297. Randomized; no masking; primary purpose prevention. Start 2021-05-02 (actual); primary completion 2021-10-02 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Metoclopramide vs Placebo for Prevention of Pneumonia in Acute Stroke
Condition
Acute Stroke
Condition
Aspiration Pneumonia
Intervention (Drug)
Metoclopramide 10mg
Intervention (Drug)
Placebo
Lead sponsor
Shaheed Zulfiqar Ali Bhutto Medical University (class: other)

Record details

Record id
cardio:ct-nct04873297
Content hash
fb49d1a82aa5735f2a93ff8d9e09eeccfc73c7f093ed0ce6721e83c2a5d36fdf